Avience Biomedicals PE Ratio
Avience Biomedicals Ltd
NSE: Avience
PE
Key Highlights
- The P/E Ratio of Avience Biomedicals Ltd is 31.8 as of 25 Jun 26 The P/E Ratio of Avience Biomedicals Ltd changed from 0 on March 2024 to 0 on March 2025 . This represents a CAGR of 0.0% over 2 years The PE Ratio of Healthcare Industry has changed from 91.6 to 62.8 in 5 years. This represents a CAGR of -7.27% The PE Ratio of Automobile industry is 5.1. The PE Ratio of Finance industry is 24.1. The PE Ratio of Healthcare industry is 39.7. The PE Ratio of IT - Software industry is 18.2. The PE Ratio of Retail industry is 70.5. The PE Ratio of Textiles industry is 35.0 in 2026 .
Historical P/E Ratio of Avience Biomedicals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Avience Biomedicals Ltd
Company Fundamentals for Avience Biomedicals Ltd
Avience Biomedicals Ltd
NSE: Avience
Share Price
Market Price of Avience Biomedicals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 25 Jun 2026 | 414.95 |
BlinkX Score for Avience Biomedicals Ltd
Asset Value vs Market Value of Avience Biomedicals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
PE Ratio of Avience Biomedicals Ltd Explained
₹227.6
Market cap
₹5
Earnings
45.0X
PE Ratio
PE Ratio of Healthcare Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Avience Biomedicals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Avience Biomedicals Ltd
Historical Revenue, EBITDA and Net Profit of Avience Biomedicals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Avience Biomedicals Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Avience Biomedicals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Avience Biomedicals Ltd
About Avience Biomedicals Ltd
- Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
- Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of Incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
- In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.
Avience Biomedicals Ltd News Hub
NSE SME Avience Biomedicals debuts with a powerful heartbeat
The scrip was listed at Rs 395.20, a 90% premium to the initial public offer (IPO) price. The stock
Read more
25 Jun 26
